Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$91.6M |
| 2 |
Abbott
ABT
|
+$75M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$74.8M |
| 4 |
JPMorgan Chase
JPM
|
+$69.6M |
| 5 |
Alibaba
BABA
|
+$68.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$96.4M |
| 2 |
AGN
Allergan plc
AGN
|
+$92.4M |
| 3 |
Johnson Controls International
JCI
|
+$76.9M |
| 4 |
Dollar General
DG
|
+$76.8M |
| 5 |
Boston Scientific
BSX
|
+$73.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.75% |
| 2 | Consumer Discretionary | 13.2% |
| 3 | Financials | 11.45% |
| 4 | Industrials | 10.99% |
| 5 | Healthcare | 10.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Fulton Financial
FULT
$4.51B
| $5.37M | 0.05% |
510,303
+478,515
| +1,505% | +$5.19M |
|
|
SYNH
502
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $5.36M | 0.05% |
92,075
-35,711
| -28% | -$1.92M |
|
503
RB Global
RBA
$16.1B
| $5.28M | 0.05% |
129,222
-85,964
| -40% | -$3.52M |
|
|
504
CALL
Boston Scientific
BSX
$73B
| $5.27M | 0.05% |
+150,000
| New | +$5.4M |
|
|
505
PUT
Alibaba
BABA
$286B
| $5.24M | 0.05% |
25,000
-75,000
| -75% | -$15.6M |
|
506
EQT Corp
EQT
$33.6B
| $5.24M | 0.05% |
439,967
-37,459
| -8% | -$491K |
|
507
PUT
American Airlines Group
AAL
$9.15B
| $5.23M | 0.05% |
400,000
| – | – |
|
|
508
Boston Scientific
BSX
$73B
| $5.2M | 0.05% |
148,178
-2,031,758
| -93% | -$73.2M |
|
|
CDK
509
DELISTED
CDK Global, Inc.
CDK
| $5.2M | 0.05% |
+125,585
| New | +$4.83M |
|
510
CALL
United Airlines
UAL
$36.7B
| $5.19M | 0.05% |
+150,000
| New | +$4.5M |
|
511
Winnebago Industries
WGO
$898M
| $5.16M | 0.04% |
77,374
-68,542
| -47% | -$3.5M |
|
512
PUT
Micron Technology
MU
$1.09T
| $5.15M | 0.04% |
+100,000
| New | +$4.72M |
|
513
H&R Block
HRB
$6.62B
| $5.12M | 0.04% |
358,461
+271,247
| +311% | +$4.29M |
|
|
ILPT
514
Industrial Logistics Properties Trust
ILPT
$554M
| $5.09M | 0.04% |
247,618
-200,927
| -45% | -$3.69M |
|
515
CALL
Lumentum
LITE
$77.7B
| $5.09M | 0.04% |
+62,500
| New | +$4.76M |
|
516
PUT
Kinross Gold
KGC
$38.9B
| $5.05M | 0.04% |
+700,000
| New | +$4.54M |
|
517
PUT
Royal Caribbean
RCL
$78.1B
| $5.03M | 0.04% |
+100,000
| New | +$4.53M |
|
|
SCPL
518
CALL
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $5M | 0.04% |
+337,500
| New | +$4.14M |
|
519
Canadian National Railway
CNI
$78.5B
| $5M | 0.04% |
+56,456
| New | +$4.7M |
|
520
Match Group
MTCH
$9.38B
| $4.99M | 0.04% |
+46,634
| New | +$3.9M |
|
521
Newmark Group
NMRK
$2.94B
| $4.98M | 0.04% |
1,024,790
+831,913
| +431% | +$3.5M |
|
522
Lamar Advertising Co
LAMR
$15.3B
| $4.96M | 0.04% |
+74,336
| New | +$4.54M |
|
|
EA
523
CALL
DELISTED
Electronic Arts
EA
| $4.95M | 0.04% |
+37,500
| New | +$4.43M |
|
524
Cushman & Wakefield Ltd
CWK
$3.48B
| $4.94M | 0.04% |
396,509
-103,232
| -21% | -$1.16M |
|
|
TBIO
525
CALL
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $4.93M | 0.04% |
+275,000
| New | +$4.15M |
|
Similar funds
Dmitry Balyasny's Q2 2020 Portfolio in Review
As of Q2 2020, Dmitry Balyasny held 1,665 positions worth $11.5B, up 37% from $8.43B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Dmitry Balyasny deployed $1.48B of net new capital in Q2 2020, opening 559 new positions and adding to 260 existing holdings. Its largest new stake was Charles Schwab: 2,556,974 shares worth $86.3M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Lowe's Companies, an estimated $96.4M trimmed.
- Dmitry Balyasny's largest Q2 2020 buy was Charles Schwab: 2,556,974 shares worth $86.3M.
- Dmitry Balyasny added most to Fiserv Inc in Q2 2020, an estimated $74.8M increase.
- Dmitry Balyasny's biggest Q2 2020 reduction was Lowe's Companies, cutting an estimated $96.4M.
- Dmitry Balyasny fully exited Allergan plc in Q2 2020, selling an estimated $92.4M.
- Dmitry Balyasny's ten largest holdings make up 9.4% of its $11.5B portfolio in Q2 2020.
- Dmitry Balyasny opened 559 new positions and closed 589 in Q2 2020.
- Dmitry Balyasny's portfolio value rose 37% quarter-over-quarter to $11.5B.
Based on Balyasny Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.